Facebook Icon Print Created with Sketch. Twitter Icon Created with Sketch. Created with Sketch. LinkedIn Icon Green Check Icon Created with Sketch. YouTube Icon Right Arrow Icon Mobile Menu Icon Chevron Right Icon Phone Icon Health Study Area: AutoImmune Disease Health Study Area: Blood Cancer Health Study Area: Cardiovascular Disease Health Study Area: Fibrosis Health Study Area: Gastrointestinal Cancer Health Study Area: Genitourinary Health Study Area: Head and Neck Cancer Health Study Area: Lung Cancer Health Study Area: Melanoma Health Study Area: Women's Cancer Health Study Area: Breast Cancer For Caregivers For Clinicians Communities FAQs For Parents For Patients Chevron Icon Bookmark Icon Map Icon Share Icon Direction Arrow Icon Direction Arrow Icon Page Icon Location Icon Search Icon External Link Icon Help Icon Error Icon Glossary Email Icon Gender Both Gender Male Gender Female Created with Sketch. Created with Sketch. Health Study Area: NASH

Please Log In/Join Now first, and then use this function!

Covid-19 (Coronavirus) Message for Patients

Note: As a result of the current COVID-19 (Coronavirus) restrictions, research sites may incorrectly be listed as recruiting or be delayed in responding to patient inquiries due to possible closures. It is suggested that interested patients awaiting a response or current study patients can contact the research site at the phone number provided to ask about study status or confirm scheduled appointments before arriving. Read more about BMS's response to COVID-19 at www.BMS.com.

Researching Lung Cancer

Lung cancer starts when cells of the lung become abnormal and begin to grow out of control

Lung Cancer Clinical Trials

Lung Cancer Clinical Trials

We are investigating experimental medications for both Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC)

Non-small cell lung cancer (NSCLC)  accounts for about 85–90% of Lung Cancer diagnoses, while Small cell lung cancer (SCLC) is composed of 10-15% of Lung Cancer diagnoses. These two types of cancer differ in how they grow and how they spread.

Answer a few questions below to see if there are clinical trials that might be right for you. 

Thank you for Considering a Clinical Trial

Below you will find  clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).

Here are some options for you to find more information:

  1. Browse the trials available on your own and Click on View Trial Details for more information, including locations that are recruiting patients.
    - or -
  2. Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you. 

Non-small Cell Lung Cancer (Advanced or Recurrent – Stages 3B and 4)

Non-small Cell Lung Cancer (Early Stage – Stages 1, 2 and 3A)

Small Cell Lung Cancer

Get updates on lung cancer clinical trials

What are you thankful for?

Explore Lung Cancer Resources

Lung Cancer by the Numbers

Lung cancer has been the most common cancer in the world for several decades, and despite advancements in treatment, has resulted in more deaths than any other cancer.

Learn More


Bristol Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -
Call 855-907-3286 or email clinical.trials@bms.com